If you receive a denial letter from your insurer, seek legal advice before appealing the decision, says a leading disability ...

LifeStance Health reports new anxiety medications are expected for 2026, featuring innovative treatments in clinical trials ...

LSD is a drug often associated with the counter-culture of the 1960s. But it is being studied as a promising therapy for ...

UCSF is seeking volunteers for a trial using LSD to treat generalized anxiety disorder - a poorly understood and potentially ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the Research and ...

Over 40 million American adults – approximately 19% – live with an anxiety disorder, according to the National Institutes of Health.

Caffeine can worsen anxiety, disrupting sleep and energy. Learn how to ditch the jitters, restore calm, and reclaim your ...

The actor has been open about the technique she employs to help with her mental health -- but with regard to whether or not ...

The year 2025 was a defining one for Incannex,” stated Joel Latham, Incannex Healthcare Chief Executive Officer. “We delivered two independent, positive Phase 2 clinical readouts across distinct CNS ...

Reunion Neuroscience, Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserve ...

Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric ...